Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kei, good play with XNPT to cut it loose early. Look like it was a insignificant FDA Approval. I bought many shares of JAG at 1.41 and will accumulate if drops below 1.30 I believe with all the world crisis, why not hold some gold. Although JAG has correlation with the gold market (GLD is physical gold), the swings can be huge(up or down) trading this junior gold miner. I will go back into biotech soon, especially when they are closer to FDA decision date. Are you confident with ARNA going into FDA decision date? Add more if pps drops?
Kei, sometimes it good to be safe than sorry. I sold my EXEL, made a little bit of profit. I bought JAG, a junior gold miner today and believe it will be a huge breakout in the coming days. The market is quite volatile these days, must be careful.
EXEL - 2 more presentations at ASCO tomorrow morning. Positive surprises-over $5.00
http://exelixis.com/resources/events/asco-2012
Kei, XNPT sure had a nice move today. Are you planning to add more shares into PDUFA?
Kei,
Will you be in ARIA and XNPT for PDUFA?
EXEL - more presentations next week at ASCO.
2 on Monday and 2 on Tuesday.
http://www.exelixis.com/resources/events/asco-2012
He shoots, he scores. EXEL should have a nice run up on Monday.
http://finance.yahoo.com/news/cabozantinib-demonstrates-evidence-anti-tumor-221500545.html
There will be more news on Monday with more presentations on the way.
EXEL - Cabozantinib Demonstrates Evidence of Anti-Tumor Effects in Heavily Pretreated Patients with Hepatocellular Carcinoma
Data Show High Rates of Objective Tumor Regression, AFP Response and Encouraging Progression-Free and Overall Survival
http://finance.yahoo.com/news/cabozantinib-demonstrates-evidence-anti-tumor-221500545.html
2 news for EXEL today, good start. Expecting 2 significant data at the ASCO. Stay tuned!
AMRN, nice run up yesterday. Good luck next week Kei.
FYI, EXEL's analyst price target covered this year, $6-$9.
http://www.streetinsider.com/rating_history.php?q=EXEL
FYI, EXEL's analyst price target covered this year, $6-$9.
http://www.streetinsider.com/rating_history.php?q=EXEL
Analyst price target covered this year, $6-$9.
http://www.streetinsider.com/rating_history.php?q=EXEL
I added EXEL today, sold my CLDX. Expect to see 2 new data at ASCO:
-Data from 40mg cohort of CRPC from RDT/NRE
-Presentation of full EXAM data in MTC
EXEL will do 9 presentations!(see link below)
http://www.exelixis.com/resources/events/asco-2012
I added EXEL today, sold my CLDX. Expect to see 2 new data at ASCO:
-Data from 40mg cohort of CRPC from RDT/NRE
-Presentation of full EXAM data in MTC
EXEL will do 9 presentations!(see link below)
http://www.exelixis.com/resources/events/asco-2012
I added EXEL today, sold my CLDX. Expect to see 2 new data at ASCO:
-Data from 40mg cohort of CRPC from RDT/NRE
-Presentation of full EXAM data in MTC
EXEL will do 9 presentations!(see link below)
http://www.exelixis.com/resources/events/asco-2012
Premarket on CLDX is green. Lets see how it opens.
Various interpretations of positive data from CLDX is causing a drop in after hours. Some think its great data, others think its not bad. There were many analysts during the web conference call this afternoon, I expect some of them to have reports in the morning before market opens. The analysts may dictate the direction of CLDX tomorrow.
Kei, lets cross our fingers for significant positive results Wednesday after hours. Good luck.
Trade2much, are you going into CLDX for Wednesday Phase 2b results?
I added a significant position today at lower 4s.
Pullback gave opportunity for me to add CLDX for May 23 phase results for breast cancer. Lets see what tomorrow brings.
Congrats, if bought OSUR yesterday. I wanted to buy today but halted, will have to catch the next one.
I think OSUR will be up over 30% in the opening. Does the price hold? 17-0 vote sounds convincing.
OSUR taking another hit today, trending to break below $9. AD Comm tomorrow. Still watching at this point.
Thanks trade2much. I've been out town all week, not much internet access. Will flip GTXI next week for profit, holding well at $3.5 range since FDA lift. I'm watching OSUR. What do you think? Its a AD Comm, better chance for upside as long as its positive votes. Whereas, FDA decision is thumbs up or down.
No news from FDA regarding clinical hold of prostate cancer phase II.
Maybe we will get some news next week.
www.fda.gov
Trade2much, I'm holding GTXI for tomorrow's news(FDA clinical hold prostate cancer phase II). I feel if no progress from FDA, stock has taken a hit already since February so the decline would not be as much. If FDA lets GTXI resume phase II trials for prostate cancer then I see a huge lift in pps. My other stock on watch, OSUR.
Here's a few tools I found useful-Price target and FDA calendar.
http://www.streetinsider.com/rating_history.php?q=osur
http://www.biopharmcatalyst.com/fda-calendar/
Made profits this morning with PLX. Today I added my next near term play in GTXI. Anyone know this one? I find this interesting. Near term catalyst for FDA to clear GTX to resume Phase II trials for prostate cancer by May 4. In february, FDA stopped GTX for trials since the larger dosages were causing blood clots and stock dropped by 50%. Since then, GTX has been working with the FDA and is addressing the issue `with lower dosages....Obama Admin has been very supportive of cancer treatments. I feel there should be good chance FDA and GTX come to some type of solution for resuming trial so the a. A few big money players have been adding to GTXI after the big drop in pps in February. A few reputable analysts indicate Phase III drug Ostarine has been viewed the bigger drug of the two.
Do you own DD and share any thoughts.
Resource: http://seekingalpha.com/article/457231-analyzing-gtx-inc-s-vast-upside-potential
Made profits this morning with PLX. Today I added my next near term play in GTXI. Anyone know this one? I find this interesting.
Near term catalyst for FDA to clear GTX to resume Phase II trials for prostate cancer by May 4. In february, FDA stopped GTX for trials since the larger dosages were causing blood clots and stock dropped by 50%. Since then, GTX has been working with the FDA and is addressing the issue `with lower dosages....Obama Admin has been very supportive of cancer treatments. I feel there should be good chance FDA and GTX come to some type of solution for resuming trial so the a. A few big money players have been adding to GTXI after the big drop in pps in February. A few reputable analysts indicate Phase III drug Ostarine has been viewed the bigger drug of the two.
Do you own DD and share any thoughts.
Resource: http://seekingalpha.com/article/457231-analyzing-gtx-inc-s-vast-upside-potential
Added GTXI today. near term catalyst for FDA to clear GTX to resume Phase II trials for prostate cancer by May 4. in february, fda stopped GTX for trials since the larger dosages were causing blood clots. since then, GTX has been working with the FDA and is addressing the issue `with lower dosages....Obama Admin has been very supportive of cancer treatments. i feel there should be good chance FDA and GTX come to some type of solution. Do your DD and good luck all.
Congrats to all PLX holders.
trade2much, congrats and to all that held through FDA Approval.
i added shares as pps went closer to $6. i am researching on my next catalyst. Any catalysts for you near term?
Either way you look at it, PLX is down 7%. The 5-10% down before FDA decision is normal from what I've experienced with FDA plays. Although I've seen big nose dives right before FDA decision, then seeing an airlift after FDA approval. Are you looking to add more shares?
PLX big day, bear raid & jitters. Lets see if there is a rally towards market close. I'm guessing news after the market close, but there may be a halt in mid-day for news release. Anyone holders?
Bear Raid on PLX. Looks interesting. If it drops closer to 6, I will be adding more shares. Anyone else playing Protalix?
Protalix (PLX) to rise into PDUFA on May 1st
http://www.mysmartrend.com/news-briefs/candlestick/protalix-biotherapeutics-winning-streak-continues-plx-0
Trade2much, I like to see another gap up going into FDA on Monday.
Good luck to all in PLX.
PLX up 5% today. Gapping up going into PDUFA on May 1st.
Trade2much, are you holding PLX?